Cholesterol reduction by MβCD decreased DAMGO-induced internalization of OPRM1, whereas excess cholesterol increased the internalization of OPRM1. Internalization of OPRM1 was quantified as the percentage loss of cell surface receptors in agonist-treated cells as described under Materials and Methods. A, N2A-OPRM1 cells were treated with different concentrations of MβCD for 3 h, then 1 μM DAMGO was added for further incubation for 2 h. B, N2A-OPRM1 cells were treated with 1 mM MβCD for 3 h (MβCD) or 1 mM MβCD for 3 h and then 10 μg/ml cholesterol for 1 h (MβCD and cholesterol), then cells were further incubated with 1 μM DAMGO for 0.5, 1, 2, and 4 h. C, N2A-OPRM1 cells were treated with different concentrations of cholesterol for 1 h, and then 1 μM DAMGO was added for further incubation of 1 h. D, N2A-OPRM1 cells were treated with 50 μg/ml cholesterol (cholesterol) for 1 h, then cells were further incubated with 1 μM DAMGO for 1, 3, 7, 10, 15, 20, 30, 60, and 120 min. Data are mean ± S.E. of at least three independent experiments performed at least in duplicate. *, P < 0.05; **, P < 0.01 versus cells without MβCD (A) or cholesterol (C) incubation or matched internalized receptors in controls (B and D).